A promising new drug for an invasive type of breast cancer
EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening the door to future clinical ...
Feb 26, 2026
0
0









